Baseline patient characteristics
| SAH | CLD | HC | |
|---|---|---|---|
| Age (years) | 47 (41–56) | 49 (47–56) | 42 (36–53) |
| Male (%) | 65 | 70 | 30 |
| MELD | 24 (22–27) | 12 (9–15) | n/a |
| CTP score (class) | 10 (C) | 7 (B) | n/a |
| INR | 1.8 (1.5–2.0) | 1.2 (1.2–1.4) | n/a |
| Bilirubin (μmol/L) | 318 (200–460) | 26 (8–44) | n/a |
| Albumin (g/L) | 24 (19–33) | 31 (28–36) | n/a |
| White cell count (×109/L) | 8.9 (5.6–13.3) | 4.9 (3.7–6.1) | n/a |
| Monocyte count (×109/L) | 1.0 (0.6–1.5) | 0.5 (0.4–0.7) | n/a |
| Neutrophil count (×109/L) | 6.9 (3.8–10.3) | 2.5 (2.4–3.7) | n/a |
| Alanine transferase (IU/L) | 42 (30–79) | 21 (17–36) | n/a |
| Aspartate transaminase (IU/L) | 127 (100–164) | 59 (34–79) | n/a |
| Serum creatinine (μmol/L) | 69 (63–104) | 63 (57–71) | n/a |
Median average values (IQR) are shown unless otherwise stated.
CTP, Child-Turcotte-Pugh score; HC, healthy control; INR, international normalised ratio; MELD, Model for End-Stage Liver Disease; SAH, severe alcoholic hepatitis.